Stemsys In-Date
Stemsys is a leading innovator in regenerative medicine, focused on developing biologically active wound care solutions using advanced extracellular matrix (ECM) technology. Known for its flagship product line XCelliStem, Stemsys specializes in porcine-derived xenograft wound powders and graft materials engineered to support cellular migration, angiogenesis, and tissue remodeling. Their decellularized porcine urinary bladder matrix (UBM) products are optimized for chronic wounds, diabetic ulcers, surgical incisions, and other complex soft tissue injuries. By harnessing the natural healing power of ECM scaffolds, Stemsys delivers effective, easy-to-use biologic matrices that promote rapid wound granulation and epithelialization. With a commitment to clinical performance and ease of application, Stemsys is redefining standards in xenograft-based wound healing technologies.
IN-DATE